FDA Approves Intuitive Surgical (ISRG) Vessel Sealer Curved Surgical Instrument

Intuitive Surgical Inc. (NASDAQ:ISRG) is one of Goldman Sachs’ top healthcare stock picks. On July 10, the company secured Food & Drug Administration approval for its new Vessel Sealer Curved. The electrosurgical instrument is designed for use with multiport da Vinci systems and represents a significant development in surgical technology.

A doctor in a hospital operating room using advanced surgical instruments.

Vessel Sealer Curved is an Intuitive Surgical’s advanced energy instrument approved for lymphatic vessel transection. It stands out due to its curved jaw design, which allows surgeons to navigate tight anatomical spaces and work around critical structures effectively. It also combines multiple functions, including sealing, cutting, grasping, and dissecting tissue.

“We designed Vessel Sealer Curved to give surgeons greater precision in narrow anatomical spaces,” said Iman Jeddi, PhD, senior vice president and general manager, da Vinci platforms & product operations. “By combining the trusted performance of Vessel Sealer Extend with a slimmer, curved jaw profile, we’re helping surgeons work more efficiently and confidently across a wide range of procedures.”

The new surgical tool aligns with the company’s three-decade focus on improving minimally invasive procedures. Consequently, it should help the company maintain its leadership position in robotic surgery, having already reported over 17 million da Vinci procedures.

Intuitive Surgical Inc. (NASDAQ:ISRG) is a healthcare company that develops, manufactures, and markets robotic-assisted surgical systems, primarily the da Vinci surgical system. Its primary goal is to make surgery more effective, less invasive, and easier for surgeons, patients, and their families.

READ NEXT: 11 Best Green Energy Penny Stocks to Buy Right Now and 10 Most Popular AI Penny Stocks to Buy According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.